Thermo Fisher Scientific’s new Cytomat 24 automated incubators and storage systems offer a sizable capacity, fast access, and wide temperature range, while eliminating contamination issues in high-throughput environments.
Thermo Fisher Scientific’s new Cytomat 24 automated incubators and storage systems, launched in May 2021, offer a sizable capacity, fast access, and wide temperature range, while eliminating contamination issues in high-throughput environments.
The new instruments utilize temperature uniformity and stability to ensure reproducibility for cell culture applications, while offering quick delivery of microtiter plates through an advanced plate shuttle system, Thermo Fisher said in a May 14, 2021 press release. The system also includes an LED touch screen, which is door mounted for convenient accessibility and viewing.
The Cytomat 24 also offers:
"As automated systems are adopted across a range of expanding applications, we continue to see new challenges arise, such as the need to minimize contamination risks in large-capacity cell culture applications," said Hansjoerg Haas, senior director and general manager, lab automation, Thermo Fisher Scientific, in the press release. "Through a fully automated ContraCon decontamination routine, the Cytomat 24 automated incubators and storage systems simplify cleaning and disinfection, providing our customers with confidence in their sample integrity. Customers are always looking for opportunities to increase productivity in their processes while ensuring the quality of the samples and results. The Cytomat 24 automated incubators and storage systems reduce the mean plate access time to 15 seconds—allowing users to achieve their research goals in less time."
Source: Thermo Fisher
Navigating Annex 1 for Early Phase Sterile Fill Finish in Clinical Supplies
November 21st 2024Stay compliant with Annex 1 for early phase sterile fill finish processes. Discover how to implement robust contamination control strategies, integrate isolator technology, and conduct integrity testing to meet stringent European Union standards. The guide provides a comprehensive look at key elements such as PUPSIT, critical zone controls, and monitoring and training for aseptic processes.
Why is the PDA Pharmaceutical Microbiology Conference the Hottest Ticket in the Industry?
October 10th 2024Get a glimpse of the power and popularity behind the PDA Pharmaceutical Microbiology Conference from two planning committee members, Julia Marre, PhD (Associate Director, Scientific and Regulatory Affairs at Pocket Naloxone Corp) and Dawn Watson (Executive Director, Global Micro Quality and Sterility Assurance at Merck). This candid conversation reveals why this industry event is so influential…and always sold out! The speakers discuss what makes the PDA Pharmaceutical Microbiology Conference so vital to industry professionals, as well as how to become a part of this dynamic professional community.
Ensuring Quality from the Start: Raw Materials Testing Support
November 21st 2024Raw Materials are the foundation of every biopharma product. Our ultimate guide highlights how our testing support can help you establish purity, identity, and quality standards, ensuring a smooth manufacturing process and adherence to regulatory requirements.
Ensure the Safety of Allogeneic Therapies with Advanced qPCR Testing
November 21st 2024Elevate your viral screening with Eurofins BioPharma Product Testing’s qPCR- based assays. Our advanced testing goes beyond standard screenings to detect even dormant and hard-to-detect pathogens, ensuring comprehensive safety in every stage of the allogeneic therapy pipeline. Protect your products – and your patients- with industry-leading sensitivity and specificity.